ReviewExperimental and therapeutic medicine2026
Autophagy-epithelial-mesenchymal transition crosstalk in acute respiratory distress syndrome: Mechanistic insights and therapeutic perspectives (Review).
Review in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute respiratory distress syndrome (ARDS) is a life-threatening pulmonary disorder frequently encountered in intensive care units, characterized by diffuse alveolar damage, intense inflammatory infiltration and progressive fibrotic remodeling. Among the mechanisms driving fibrosis, the epithelial-mesenchymal transition (EMT) has gained increasing recognition as a key contributor to the generation of fibroblasts and extracellular matrix deposition. Autophagy, a tightly regulated intracellular degradation and recycling process, serves a context-dependent role in EMT regulation and lung injury. While basal autophagy supports pulmonary cellular homeostasis, dysregulated or excessive autophagy may exacerbate tissue injury and maladaptive repair. The literature has previously highlighted both classical macroautophagy and selective autophagy pathways, including mitophagy, endoplasmic reticulum-selective autophagy and ferritinophagy, as modulators of EMT dynamics and fibrotic outcomes. However, the mechanistic associations between specific autophagy subtypes and EMT in ARDS remain poorly defined and occasionally contradictory. In the present review, current evidence on autophagy-EMT crosstalk in ARDS is critically appraised, conceptual gaps and controversies are identified and further potential mechanistic frameworks and research priorities are summarized. Such investigation may help inform the rational targeting of autophagy pathways in future ARDS therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.